We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


BioVendor Instruments a.s. is involved in research & development related to automation and optimization of processes ... read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Urine Neutrophil Gelatinase-Associated Lipocalin Predicts Acute Kidney Injury

By LabMedica International staff writers
Posted on 15 Nov 2022
Print article
Image: A Human Lipocalin-2/ neutrophil gelatinase-associated lipocalin (NGAL) sandwich ELISA kit (Photo courtesy of Epitope Diagnostics Inc.)
Image: A Human Lipocalin-2/ neutrophil gelatinase-associated lipocalin (NGAL) sandwich ELISA kit (Photo courtesy of Epitope Diagnostics Inc.)

Despite the increasing heterogeneity of etiology, making a definitive and timely diagnosis of acute kidney injury (AKI) remains challenging. Currently, the diagnosis of AKI is still based on elevated serum creatinine concentration or decreased urinary excretion. However, increased serum creatinine and decreased urine volume usually occur 48 hours after renal injury.

Contrast-associated acute kidney injury (CA-AKI) is an early complication after percutaneous coronary intervention (PCI). Depending on the study subjects, the rate of acute kidney injury can occur from 4.2% to 50%. CA-AKI after PCI is often associated with contrast drugs, hemodynamic instability, old age, pre-existing chronic kidney disease, or a combination of diabetes and hypertension.

Medical Scientists at the Vietnam Military Medical University (Hanoi, Vietnam) included in a study 509 patients with chronic coronary artery disease, indicated for planned percutaneous coronary intervention at two centers. The patients were divided into two groups: group 1, 153 elderly patients ≥70 years old and group 2, 356 patients <70 years old. The team collected fasting morning venous blood plasma to determine concentrations of hs-CRP, hs-TnT, ALT, AST, cholesterol, triglyceride, HDL-C, LDL-C, electrolyte, glucose, urea, and creatinine.

The patient's 24 hour-urine sample was collected on the day before the procedure. After 24 hours, the team measures the urine volume, took 5 mL of urine to determine the neutrophil gelatinase-associated lipocalin (NGAL) level, and then calculated the 24-h urine NGAL concentration. Urine NGAL was measured by the Human Lipocalin-2/NGAL ELISA kit (BioVendor, Brno, Czech Republic) based on the sandwich enzyme immunoassay method. All patients had their glomerular filtration rate (eGFR) calculated based on the MDRD formula.

The investigators reported that the ratio of CA-AKI in group 1 was 23.5% which was higher than that of group 2 (8.7%). Urine NGAL level in group 1 was significantly higher than that of group 2 (31.3 (19.16–55.13) ng/mL versus 19.86 (13.21–29.04) ng/mL. At a cut-off value of 44.43 ng/ml, urinary NGAL had a predictive value for CA-AKI in all patients (AUC = 0.977). Especially at a cut-off value of 44.14 ng/mL, urinary NGAL had a predictive value for CA-AKI in elderly patients (AUC = 0.979).

The authors concluded that the rate of CA-AKI after PCI in elderly patients was 23.5%. Urine NGAL before PCI has a good predictive value for CA-AKI in elderly patients who received planned percutaneous coronary intervention. The study was published on November 10, 2022 in the Journal of Clinical Laboratory Analysis.

Related Links:
Vietnam Military Medical University

Gold Supplier
Auto Urinary Sediment Analyzer
Hematology Reagents
Hematology Reagents
Celiac Disease PCR Test
XeliGen XL
Lab Incubator

Print article


Molecular Diagnostics

view channel
Image: Researchers have identified the origin of subset of autoantibodies that worsen lupus (Photo courtesy of Pexels)

Lupus Biomarker Testing Could Help Identify Patients That Need Early and Aggressive Treatment

Systemic lupus erythematosus (SLE) is an autoimmune disease that occurs when the body's antibodies, which usually protect against infections, attack healthy cells and proteins. These autoantibodies can... Read more


view channel
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Late-stage bowel cancer patients usually undergo a series of chemotherapies and targeted medicines for cancer treatment. However, the responses to the last-line chemotherapy treatment trifluridine/tipiracil... Read more


view channel
Image: Use of DBS samples can break barriers in hepatitis C diagnosis and treatment for populations at risk (Photo courtesy of Pexels)

DBS-Based Assay Effective in Hepatitis C Diagnosis and Treatment for At Risk Populations

In a bid to eliminate viral hepatitis as a public health threat by 2030, the World Health Organization (WHO) has put forth a proposed strategy. To this end, researchers at the Germans Trias i Pujol Research... Read more


view channel
Image: New research has opened a path for fast and accurate cancer diagnosis (Photo courtesy of Imagene)

AI-Based Image Analysis Software Profiles Cancer Biomarkers in Real Time

Lung cancer is the most widespread type of cancer worldwide, resulting in approximately 1.76 million fatalities annually. Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer diagnoses... Read more


view channel
Image: Live view of non-fluorescent specimens using the glowscope frame (Photo courtesy of Winona State University)

Device Converts Smartphone into Fluorescence Microscope for Just USD 50

Fluorescence microscopes are utilized to examine specimens labeled with fluorescent stains or expressing fluorescent proteins, like those tagged with green fluorescent protein. However, since these microscopes... Read more


view channel
Image: The global antimicrobial resistance diagnostics market size is expected to reach USD 5.7 billion by 2028 (Photo courtesy of Pexels)

Global Antimicrobial Resistance Diagnostics Market Driven by Increasing Hospital-Acquired Infections

Antimicrobial drugs are intended to counteract the harmful effects of microbes and promote a healthy life. However, their excessive use can result in the development of resistance, commonly referred to... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.